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Background-—The left atrial posterior wall (PW) often contains sites required for maintenance of atrial fibrillation (AF). Electrical
isolation of the PW is an important feature of all open surgeries for AF. This study assessed the ability of current ablation
techniques to achieve PW isolation (PWI) and its effect on recurrent AF.
Methods and Results-—Fifty-seven consecutive patients with persistent or high-burden paroxysmal AF underwent catheter
ablation, which was performed using an endocardial-only (30) or a hybrid endocardial–epicardial procedure (27). The catheter
ablation lesion set included pulmonary vein antral isolation and a box lesion on the PW (roof and posterior lines). Success in
creating the box lesion was assessed as electrical silence of the PW (voltage <0.1 mV) and exit block in the PW with electrical
capture. Cox proportional hazards models were used for analysis of AF recurrence. PWI was achieved in 21 patients (36.8%), more
often in patients undergoing hybrid ablation than endocardial ablation alone (51.9% versus 23.3%, P=0.05). Twelve patients
underwent redo ablation. Five of 12 had a successful procedural PWI, but all had PW reconnection at the redo procedure. Over a
median follow-up of 302 days, 56.1% of the patients were free of atrial arrhythmias. No parameter including procedural PWI was a
statistically significant predictor of recurrent atrial arrhythmias.
Conclusions-—PWI during catheter ablation for AF is difficult to achieve, especially with endocardial ablation alone. Procedural
achievement of PWI in this group of patients was not associated with a reduction in recurrent atrial arrhythmias, but reconnection
of the PW was common. ( J Am Heart Assoc. 2016;5:e003885 doi: 10.1161/JAHA.116.003885)
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I solation of the left atrial (LA) posterior wall (PW) as astrategy for management of complex atrial fibrillation (AF),
in addition to standard pulmonary vein antral isolation, has
been investigated with variable results.1–6 LA PW isolation
(PWI) is attempted with the intent of eliminating triggers and
drivers often found on the PW and with the goal of debulking
the atrial tissue. LA PWI has been part of the surgical Maze
procedure,7,8 hybrid endocardial–epicardial ablation, and
endocardial-only ablation of AF.9–13 It has yielded good
results in open surgical procedures, but results from previous
endocardial-only ablation studies are conflicting.1,4
LA PWI is challenging to achieve with the currently
available endocardial radiofrequency catheter ablation proce-
dure because of the need for long linear lesions with
conduction block across the LA roof and lower PW. Creating
a lower PW linear lesion without a gap is particularly
challenging because ablation over the esophagus is frequently
required. Moreover, durability of LA PWI is not guaranteed by
procedural success with current ablation technology. In this
paper, we presented our experience with PWI and its efficacy
as a strategy for management of patients with complex AF
substrates, using endocardial-only or hybrid surgical epicar-
dial and endocardial ablation procedures.
Methods
Patient Population
Consecutive patients with persistent or high-burden paroxys-
mal AF underwent ablation with a catheter-based endocardial-
only or hybrid endocardial–epicardial ablation procedure with
a plan for LA PWI over a period of August 2012 to November
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2013. Patients selected for hybrid ablation were considered
unlikely to benefit from endocardial ablation alone because of
longstanding persistent AF, the presence of significant
structural heart disease (especially LA dilatation), and failure
after ≥1 endocardial ablation session. The endocardial PWI
was performed in patients with LA dilatation, with long-
duration AF, or with AF that did not terminate after pulmonary
vein isolation alone.
Our institutional review board approved acquisition of data
for the study, and all patients provided informed consent.
Radiofrequency Ablation
Radiofrequency ablation was performed on all patients, using
either an endocardial-only or a combined epicardial–endocar-
dial procedure. All procedures were performed at the
University of North Carolina Hospitals electrophysiology
laboratory.
Endocardial ablation
All patients with persistent AF or with paroxysmal AF and a
CHADS2 score ≥1 underwent preprocedural transesophageal
echocardiography to rule out intracardiac thrombus before
the procedure, and intravenous heparin was administered
with a target activated clotting time of >350 seconds before
transseptal access. LA access was achieved by double
transseptal puncture. A decapolar circular mapping catheter
was used to acquire an anatomic map of the pulmonary veins
and the left atrium (EnSite/NaVx [St Jude Medical] or Carto
[Biosense Webster]).
Endocardial ablation was performed using an irrigated
ablation catheter (Chili II [Boston Scientific], Thermocool SF
[Biosense Webster], or Safire Blu [St Jude Medical]) guided by
a circular mapping catheter. Power of 25 to 40 W was used
and was reduced to 20 to 30 W while ablating on the PW.
Esophageal temperature was monitored, and power delivery
was interrupted for temperature elevations ≥0.4°C. All
patients underwent pulmonary vein antral isolation. Lesion
placement was continued until entrance block was demon-
strated either as loss of the signals within the pulmonary vein
or as the appearance of a dissociated pulmonary vein
potential. A roof line was created anteriorly across the LA
roof that connected the 2 superior pulmonary veins. A line of
lesions was created along the endocardial posterior left
atrium to connect the left and right inferior pulmonary veins to
isolate the PW between the pulmonary vein pedicles. Addi-
tional linear ablation or ablation guided by complex fraction-
ated atrial electrograms was performed at the operator’s
discretion in patients who remained in AF. When the
arrhythmia organized into either an atrial flutter or a focal
atrial tachycardia, this was mapped and ablated. If AF
persisted, ibutilide was administered intravenously as
necessary and an external shock was delivered as necessary
to cardiovert the patient to normal sinus rhythm. Cavotricus-
pid isthmus ablation was performed in all patients with
persistent AF and in those with paroxysmal AF who had a
history of typical atrial flutter.
After conversion to sinus rhythm, a voltage map of the left
atrium was acquired, and the area of electrical silence
encompassed by the ablation lines (defined as voltage
<0.1 mV) was assessed on the map. Additional lesions along
the ablation lines were placed if the PW still had electrical
activity. Electrical block was defined as pacing from the PW
with PW capture and exit block to the remainder of the atrium
and/or the appearance of a dissociated potential on the PW.
Hybrid epicardial–endocardial procedure
Hybrid epicardial–endocardial procedures were performed in
a hybrid electrophysiology/operating room suite with inte-
grated fluoroscopy and a 3-dimensional mapping and imaging
system along with endoscopy and general anesthesia. The
epicardial procedure was initially performed by a cardiotho-
racic surgery team through either a subxiphoid transdiaphrag-
matic access or a right minithoracotomy/thoracoscopic
access. The details of the epicardial part of the procedure
were described previously.9,14
Subsequent to the epicardial portion of the procedure, the
endocardial procedure was performed in a manner similar to the
endocardial-only ablation procedure. After transseptal access, a
3-dimensional electroanatomic map with voltage mapping was
acquired to define the ablation lines made during the epicardial
part of the procedure and to check for silence and isolation of the
PW box and the pulmonary veins. If the pulmonary veins were not
isolated, endocardial lesions were placed as necessary to achieve
block guided by a circular mapping catheter. The integrity of the
roof line and the low posterior line was checked with the voltage
map, and documentation of entrance block into the PW box and
demonstration of exit blockwere performed once the patient was
in sinus rhythm. Additional ablation lesions were then placed in a
stepwise fashion in a manner similar to the endocardial-only
procedure.
Postablation care
All patients were observed overnight in the hospital, with
clinical assessment immediately following the procedure and
before discharge. Length of hospitalization was prolonged for
antiarrhythmic drug loading if indicated. Recovery and
discharge of patients after a hybrid ablation procedure took
longer, and recovery from the surgical epicardial part of the
ablation procedure and management of the drain were
additional determinants of length of hospital stay.
After ablation, anticoagulation with warfarin or one of the
newer oral anticoagulants was reinitiated with bridging
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enoxaparin and/or intravenous heparin, as appropriate. Oral
anticoagulant was administered for at least 6 weeks in all
patients and was continued subsequently based on risk
factors for cerebrovascular accident. A class I or III antiar-
rhythmic medication was initiated in all patients after ablation.
The choice and duration of antiarrhythmic medication was
made on an individual basis taking clinical factors into
consideration but was not discontinued at <6 weeks.
Follow-up
Patients were followed at 6 weeks and at 3, 6, and
12 months following the ablation procedure. A clinical
interview, a full clinical examination, and electrocardiography
were performed at each follow-up. Patients with an implanted
pacemaker or implantable cardioverter-defibrillator had inter-
rogation of their device to look for any evidence of AF at each
visit. Long-term electrocardiographic cardiac monitoring for
recurrence was done at 3 and 12 months to assess for
asymptomatic AF. All patients with combined epicardial–
endocardial ablation had implantation of a looping ECG event
recorder (Medtronic Reveal) to monitor recurrent AF. Recur-
rence was defined as >30 seconds of documented AF or atrial
flutter/atrial tachycardia occurring after a blanking period of
3 months after ablation or >2 minutes in patients with
implanted recorders (the lower limit of detection of the
device).
Statistical Analysis
Continuous variables were summarized as means and stan-
dard deviations, and categorical variables were summarized
as percentages. The means of the continuous variables were
compared using the t test, and the frequencies between
groups were compared with the chi-squared test or Fisher’s
exact test, as appropriate. The predictors of recurrent AF after
catheter ablation were analyzed with Cox proportional hazards
models using univariate and multivariate models. Kaplan–
Meier curves were generated for estimated probability of
recurrence of AF on follow-up. The open source software R (R
Foundation for Statistical Computing) was used for all
statistical analysis.
Results
Clinical Characteristics
Fifty-seven patients undergoing attempted PWI were included
in the analysis. In total, 27 patients (47.4%) underwent hybrid
ablation, and the remainder underwent endocardial-only
ablation. Clinical characteristics are summarized in Tables 1
and 2. The age of the study cohort was 62.48.8 years, and
78.9% of the cohort was male. LA size for the cohort was
4.80.6 cm, and left ventricular ejection fraction was
53.410.0%. The CHA2DS2-VaSc score was 2.61.4. Six
patients (10.5%) had high-burden paroxysmal AF, and the rest
had persistent AF. The cohort had significant comorbidities
Table 1. Summary Clinical Data in Hybrid and
Endocardial-Only AF Ablation
Variables All
Endocardial-
Only Group
Hybrid
Group P Value
Age, y 62.48.8 63.78.8 60.98.7 0.11
Male sex, % 78.9 73.3 85.2 0.44
BMI 33.45.9 32.56.4 34.45.1 0.11
LVEF, % 53.410.0 53.69.3 53.310.9 0.45
Left atrial
diameter, cm
4.80.6 4.50.5 5.00.7 0.005
History (%)
Hypertension 82.5 80.0 85.2 1.00
Diabetes
mellitus
29.8 36.7 22.2 0.37
Coronary artery
disease
24.6 23.3 29.6 0.81
Congestive
heart failure
38.6 30.0 48.1 0.26
CHA2DS2-VaSc 2.61.4 2.71.4 2.51.4 0.31
AF indicates atrial fibrillation; BMI, body mass index; LVEF, left ventricular ejection
fraction.
Table 2. Summary of Baseline Clinical Data in Patients With
and Without Recurrent AF
Variables All
Patients With
Recurrence
Patients
Without
Recurrence P Value
Age, y 62.48.8 60.28.5 64.18.8 0.10
Male sex, % 78.9 76.0 81.3 0.87
BMI 33.45.9 34.76.3 32.35.4 0.14
LVEF, % 53.410.0 53.011.0 53.89.3 0.76
Left atrial
diameter, cm
4.80.6 4.90.7 4.70.5 0.30
History (%)
Hypertension 82.5 84.0 81.3 1.00
Diabetes
mellitus
29.8 24.0 34.4 0.58
Coronary artery
disease
24.6 24.0 25.0 1.00
Congestive
heart failure
38.6 36.0 40.6 0.93
CHA2DS2-VaSc 2.61.4 2.31.5 2.81.3 0.22
AF indicates atrial fibrillation; BMI, body mass index; LVEF, left ventricular ejection
fraction.
DOI: 10.1161/JAHA.116.003885 Journal of the American Heart Association 3
Posterior Wall Isolation for AF Kumar et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
predisposing to AF, including hypertension (82.5%), heart
failure (38.6%), diabetes mellitus (29.8%), and history of
coronary artery disease (24.6%). Overall, 15 patients (9 in the
hybrid ablation group and 6 in the endocardial-only ablation
group) had a history of ≥1 previous ablation procedure for AF.
Hybrid and endocardial-only ablation patients were clinically
similar except for larger LA size in the hybrid group (5.00.7
versus 4.50.5 cm, P=0.005) (Table 1).
Catheter Ablation
Figure 1 shows endocardial voltage maps for a patient with
electrical silence of the PW (Figure 1A) (defined as no
measured voltage >0.1 mV) after endocardial-only ablation
and a patient for whom silence of the PW could not be
achieved despite exhaustive ablation (Figure 1B). Figure 2
shows an example of entrance and exit block in the PW. In
Figure 2A, an isolated PW potential is evident during sinus
rhythm, and this potential could be captured by PW pacing
(Figure 2B), confirming entrance and exit block in the PW in
this patient. An electrically silent PW by voltage map was
achieved in 44% of the patients, but PWI with documented exit
block was achieved in only 37% of the patients. PWI was
achieved more frequently in patients undergoing hybrid
ablation than endocardial ablation alone (51.9% versus
23.3%, P=0.05). LA size, left ventricular systolic function,
and the presence of hypertension, diabetes mellitus, or
coronary artery disease did not predict the likelihood of
successful PWI.
The total radiofrequency duration for endocardial ablation
was 89.439.0 minutes, total fluoroscopy time was
64.420.5 minutes, and a total of 15062 endocardial lesions
were placed. Although fluoroscopy times were similar in hybrid
and endocardial-only procedures (6320 versus 6521 min-
utes, P=0.79), total endocardial radiofrequency duration was
considerably lower in patients undergoing hybrid ablation
(6219 versus 11435 minutes, P<0.001). The number of
endocardial lesions placed was also lower in patients undergo-
ing hybrid procedures (10734 versus 18857, P<0.001).
Ablation of complex fractionated atrial electrograms was
performed in 28 patients (49.1% of patients, 60.0% in the
endocardial-only group versus 37.0% in the hybrid ablation
group; P=0.14), and mitral isthmus ablation was performed in
30 patients (52.6% of patients, 60.0% in the endocardial-only
group versus 44.4% in the hybrid ablation group; P=0.36).
Four patients were in sinus rhythm at the start of the
procedure. One of these patients was planned for endocardial-
only ablation, and 3 were planned for hybrid ablation; all of the
latter had recurred after 2 previous endocardial ablations. Of
the 24 hybrid ablation patients in AF, termination of AF was
seen in 4 with epicardial ablation alone (all of them into sinus
rhythm), and AF terminated in 11 with additional endocardial
ablation (9 into sinus rhythm and 2 into atrial flutter). Of 29
endocardial-only ablation patients in AF at the start of the
procedure, AF terminated in 10 (8 into sinus rhythm and 2
into atrial flutter). Termination into either sinus rhythm or
atrial flutter at the end of the procedure in patients not
presenting in sinus rhythm was seen more often in patients
undergoing the hybrid ablation procedure (15 of 24 patients,
62.5%) compared with patients undergoing the endocardial-
only procedure (10 of 29 patients, 34.5%; P=0.04).
Recurrence of AF
Over a median postablation follow-up of 302 days, recurrent
atrial arrhythmia was seen in 25 patients (43.9%). Of these 25
patients, 7 had atrial tachycardia, and the rest had AF as the
mode of recurrent arrhythmia. Only 12 of these patients opted
for a redo ablation; the symptoms were reasonably well
controlled with antiarrhythmic medications in the remainder.
Patients with and without recurrent atrial arrhythmias did not
have statistically significant differences in various clinical
parameters (Table 2). No clinical factor or procedural factor,
including PWI and LA size, was a statistically significant
predictor of recurrent AF (Table 3). PWI did not affect the risk
of recurrence in a univariate model in the entire cohort
(Figure 3). Cox regression for subgroups of patients
A
B
Figure 1. A, Lesion sets to an isolated posterior wall, with a silent
posterior wall on voltage mapping after completion of ablation. B, A
patient unable to isolate the posterior wall despite lesion sets for
posterior wall isolation, with electrical activity in areas of the
posterior wall. Gray areas show bipolar peak-to-peak voltage during
sinus rhythm <0.1 mV, and purple areas show bipolar voltage
during sinus rhythm of >0.5 mV.
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undergoing endocardial-only ablation and hybrid ablation did
not show any statistically significant predictor for recurrence
in the multivariate model except for LA size in the hybrid
ablation subgroup (hazard ratio 4.26, 95% CI 1.09–16.74;
P=0.038).
Eight patients in the endocardial-only ablation group and 4
patients in the hybrid ablation group had redo ablation
procedures. Three of 4 in the hybrid group and 2 of 8 in the
endocardial-only group had PWI at the end of the index
procedure. The PW was not isolated at the beginning of the
redo procedure for any of these 5 patients.
Complications
None of the patients had stroke, pericardial tamponade, or
any major bleed requiring transfusion.
Lead I
CS prox
Lead I
CS prox
CS dist
PW pace
PW map
STIM
PW map
B
A
Figure 2. An example of entrance and exit block in the PW. A, An isolated PW potential (red arrow)
evident during sinus rhythm. B, Capture of PW (green arrows) with pacing without capturing the rest of the
atrium, proving exit block from the PW box. CS indicates coronary sinus; CS dist, bipole recording distal
coronary sinus; CS prox, bipole recording proximal coronary sinus; PW, posterior wall; PW map, bipole
recording potential inside the posterior wall box; PW pace, bipole used to pace from the posterior wall box.
STIM, stimulation channel.
Table 3. Cox Univariate and Multivariate Analysis of
Predictors of Recurrent Atrial Arrhythmias
Variable
Unadjusted HR
(95% CI) P Value
Adjusted HR
(95% CI) P Value
Posterior
wall
isolation
1.53 (0.66–3.55) 0.32 1.33 (0.50–3.56) 0.57
LA size 1.69 (0.83–3.42) 0.15 2.06 (0.89–4.75) 0.09
BMI 1.05 (0.99–1.12) 0.13 1.04 (0.95–1.13) 0.44
Age 0.948 (0.906–0.992) 0.02 0.95 (0.906–1.003) 0.066
Previous
AF
ablation
1.28 (0.53–3.06) 0.59 1.10 (0.39–3.08) 0.85
Hybrid
ablation
1.21 (0.55–2.66) 0.64 0.73 (0.29–1.80) 0.49
AF indicates atrial fibrillation; BMI, body mass index; HR, hazard ratio; LA, left atrium.
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Figure 3. Kaplan–Meier curve showing freedom from atrial
arrhythmias after index ablation procedure in patients with (green
line) and without (red line) procedural isolation of the posterior wall
(no statistically significant difference in survival free of atrial
arrhythmia).
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Discussion
In this study we investigated PWI as a strategy for
radiofrequency ablation for AF. We assessed the achievement
of procedural isolation of the PW by both voltage mapping and
pacing techniques and declared procedural success only
when there were demonstrable exit and entrance blocks. With
our rigorous assessment for isolation, the rate of successful
PWI was low. Even the patients who achieved procedural PWI
did not show lower recurrence of AF on follow-up after the
procedure. Importantly, in a small subset of patients who
underwent redo procedures, reconnection of the PW was
common. For this reason, it could be argued that the efficacy
of PWI in catheter-based and hybrid procedures remains an
open question. Its apparent efficacy in surgical Maze proce-
dures would argue that our somewhat disappointing results
occurred because of difficulty in achieving durable PWI with
current radiofrequency ablation techniques.
The PW may be important in the initiation and maintenance
of AF for multiple reasons. Embryologically, the LA PW pedicle
between the pulmonary veins has the same origin as the
pulmonary veins and thus might share a similar propensity for
housing triggers. The PW and roof contain favorable condi-
tions for reentry. Complex fiber orientation within the PW
creates anisotropy, allowing conduction block, reentry, and
wavebreak.15 The pulmonary vein antra and PW may be
subject to increased wall stress compared with other areas of
the atria.16 In chronic AF related to mitral valve disease,
histopathological examination reveals greater myocytolysis
and interstitial changes in the PW.17 This fibrosis in the PW
promotes slow conduction and reentry and may provide
stabilizing anchor points for spiral waves.18 Consequently, it is
not surprising that rotors, focal sources of AF, and important
complex fractionated atrial electrograms are often localized to
the PW and roof.19–21 Electrical isolation of the PW would
eliminate these triggers and drivers of AF while debulking the
atria, leaving less remaining available substrate for fibrillation.
In addition to the mechanistic considerations to support
PWI as a strategy for ablation of AF, the efficacy of the Cox-
Maze procedure in the surgical treatment of AF also suggests
the importance of the LA PW in the pathogenesis of AF. All
variants of a Maze-like procedure, including modified Maze
procedures performed by minimally invasive surgical
approaches, have isolation of LA PW as the end result of
the procedure.7,8,22,23 Our hypothesis also stems from our
previous observation9 of successful elimination of signals on
the PW during a hybrid epicardial–endocardial procedure with
a combination of minimally invasive surgical epicardial
ablation and catheter-based endocardial ablation and favor-
able results in controlling AF.
In our study, we could isolate the PW with endocardial
ablation in only 23% of the patients. Even with hybrid ablation,
the rate of achieving PWI was relatively low at 52%. Achieving
PWI requires aggressive ablation on the PW over the
esophagus, and often, adequate lesion placement may be
limited by esophageal temperature rises. Previous studies
evaluating PWI have shown variable success in achieving PWI,
with success rates ranging from 19% to as high as 96%.1,3–6,24
Hybrid ablation series have not documented PWI except for
Muneretto et al, with isolation after epicardial ablation alone
in 83% and completion of isolation in the rest of the patients
with endocardial ablation.12 Nevertheless, the criteria and
rigor of demonstrating isolation in these studies have been
variable. In our series, PWI was rigorously evaluated in each
patient, as described in the Methods.
In this cohort, no statistically significant difference was
seen in recurrence of atrial arrhythmias between those with
complete PWI and those with incomplete lines. Although this
finding is unexpected, it is not inexplicable. Two questions
need attention in this regard. The first is related to the
durability of PWI, and the second is the question of
incremental benefit of PWI in treating AF over and above
the rest of the ablation procedure.
Placement of a durable lesion with durable PWI using
radiofrequency catheter ablation is itself challenging. Acute
procedural success of PWI inmany such patientsmay be limited
by tissue edema developing during the procedure. In contrast,
development of edema and inflammation during placement of
ablation lesions may make the damage reversible on subsi-
dence of edema and inflammation, and thus lesions may not be
durable. Lack of durable isolation with current catheter ablation
techniques has been very well demonstrated in multiple
pulmonary vein isolation series.25,26 In this series, 37% of the
patients had dissociated PWs at the end of index procedure,
with questionable durability of isolation. Of the 5 patients with
PWI who underwent a redo ablation later, conduction to the PW
recurred in all. Similar findings were seen in other studies of
PWI, with a large fraction of patients studied for redo
procedures having a reconnected PW. This may be due to
overrepresentation of PW reconnection in patients undergoing
redo procedures. Nevertheless, it should be noted that even
with incomplete lines, it is possible that sites containing driver
mechanisms in the roof or low PWmay have been coincidentally
interrupted if they were in the path of incomplete lines.
Inability to achieve durable block across linear lesions may
also explain the findings of the STAR-AF II trial, which did not
demonstrate any benefit of additional linear ablation beyond
pulmonary vein isolation for AF-free survival. It would not be
surprising that with the use of similar ablation technology, the
chances of achievement of durable block across the linear
lesions in this study also would have been low and thus
translated into no benefit of additional linear ablation in these
patients.27
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Although the additional efficacy of adding PWI to pulmonary
vein isolation was not assessed in this study, it has been
evaluated in 2 previous studies. Tamborero et al found no
additional benefit in completing PWI by adding a low posterior
line to a roof line compared with a roof line alone.1 Lim et al
compared single-ring PWI to wide-area pulmonary vein isolation
and saw no reduction in recurrent atrial arrhythmias. Although
rates of AF were reduced, recurrent macroreentry was greater
in the single-ring group.4 Nevertheless, concerns about the
durability of PWI leave these data open to question.
Limitations
These data are from a relatively small series of patients at a
single center. A significant fraction of the patients included in
the study underwent an epicardial ablation procedure as part
of a hybrid surgical epicardial and catheter-based endocardial
ablation procedure. The numbers are not large enough to
allow subgroup analysis, especially with a small fraction of the
patients achieving PWI. Moreover, durability of PWI with the
available ablation techniques is an open question, and
reassessment of durable isolation has been documented in
only a small fraction of patients returning for redo ablation
and thus with inherent selection bias.
Conclusions
When the outcome of LA PWI is assessed rigorously using
pacing techniques in addition to voltagemapping, PWI during AF
ablation procedure is difficult to achieve with current ablation
techniques, especially with endocardial-only ablation. Proce-
dural isolation of the LA PW does not appear to influence
recurrence of AF in this patient cohort; however, with
questionable durability of isolation with current radiofrequency
ablation techniques, the value of PWI as a strategy for AF
ablation remains an open question.
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